Russell
Herndon comes to Hydra with over 25 years of experience in the
healthcare and biotechnology industries, with a proven track record in
building successful business infrastructures, pioneering innovative
corporate and regulatory processes and advancing products through
development. His industry experience includes senior management
positions at Genzyme Corporation and Antigenics Inc., where he led some
of the companies' most strategic and i...
more
Russell
Herndon comes to Hydra with over 25 years of experience in the
healthcare and biotechnology industries, with a proven track record in
building successful business infrastructures, pioneering innovative
corporate and regulatory processes and advancing products through
development. His industry experience includes senior management
positions at Genzyme Corporation and Antigenics Inc., where he led some
of the companies' most strategic and important initiatives. At
Antigenics, Russ served as Chief Operating Officer and President. From
November 2003 through December 2005 he held the position of President
of Commercial Operations. He was with Genzyme Corporation from 1989
through 2000 holding various management positions, including President
of Genzyme Tissue Repair, Senior Vice President of Genzyme Tissue
Repair and Vice President of regulatory affairs for Genzyme
Corporation. Prior to joining Genzyme, Russ gained extensive experience
in the area of quality systems, including management positions at
Patton Company, Paco Research & Development and Alcon Laboratories
Incorporated. Russ received a bachelor's degree in biology from Barton
College and is a graduate of the Management Development Program at
Harvard Business School.
less
